ArticleJournal of imaging2024
Deep Learning-Based Diagnosis Algorithm for Alzheimer's Disease.
Article in Journal of imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Deep learning-based cognitive impairment brain imaging analysis: New methods, new technologies, and new paradigms.Neural regeneration research · 2026Article
- A Dual Stream Deep Learning Framework for Alzheimer's Disease Detection Using MRI Sonification.Journal of imaging · 2026Article
- Alzheimer's disease detection from structural brain MRI using FFA U-Net segmentation and transfer learning.Frontiers in neuroscience · 2026Article
- Evaluating the Impact of 2D MRI Slice Orientation and Location on Alzheimer's Disease Diagnosis Using a Lightweight Convolutional Neural Network.Journal of imaging · 2025Article
- 3D-NASE: A Novel 3D CT Nasal Attention-Based Segmentation Ensemble.Journal of imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Alzheimer's disease (AD), a degenerative condition affecting the central nervous system, has witnessed a notable rise in prevalence along with the increasing aging population. In recent years, the integration of cutting-edge medical imaging technologies with forefront theories in artificial intelligence has dramatically enhanced the efficiency of identifying and diagnosing brain diseases such as AD. This paper presents an innovative two-stage automatic auxiliary diagnosis algorithm for AD, based on an improved 3D DenseNet segmentation model and an improved MobileNetV3 classification model applied to brain MR images. In the segmentation network, the backbone network was simplified, the activation function and loss function were replaced, and the 3D GAM attention mechanism was introduced. In the classification network, firstly, the CA attention mechanism was added to enhance the model's ability to capture positional information of disease features; secondly, dilated convolutions were introduced to extract richer features from the input feature maps; and finally, the fully connected layer of MobileNetV3 was modified and the idea of transfer learning was adopted to improve the model's feature extraction capability. The results of the study showed that the proposed approach achieved classification accuracies of 97.85% for AD/NC, 95.31% for MCI/NC, 93.96% for AD/MCI, and 92.63% for AD/MCI/NC, respectively, which were 3.1, 2.8, 2.6, and 2.8 percentage points higher than before the improvement. Comparative and ablation experiments have validated the proposed classification performance of this method, demonstrating its capability to facilitate an accurate and efficient automated auxiliary diagnosis of AD, offering a deep learning-based solution for it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.